| Type I interferon–mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy A Psarras, P Emery, EM Vital Rheumatology 56 (10), 1662-1675, 2017 | 191 | 2017 |
| A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features YM El-Sherbiny, A Psarras, MY Md Yusof, EMA Hensor, R Tooze, ... Scientific reports 8 (1), 5793, 2018 | 126 | 2018 |
| Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity A Psarras, A Alase, A Antanaviciute, IM Carr, MY Md Yusof, M Wittmann, ... Nature communications 11 (1), 6149, 2020 | 121 | 2020 |
| Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status MYM Yusof, A Psarras, YM El-Sherbiny, EMA Hensor, K Dutton, ... Annals of the rheumatic diseases 77 (10), 1432-1439, 2018 | 117 | 2018 |
| Emerging concepts of type I interferons in SLE pathogenesis and therapy A Psarras, M Wittmann, EM Vital Nature reviews Rheumatology 18 (10), 575-590, 2022 | 95 | 2022 |
| A critical view on cardiovascular risk in systemic sclerosis A Psarras, S Soulaidopoulos, A Garyfallos, G Kitas, T Dimitroulas Rheumatology international 37, 85-95, 2017 | 63 | 2017 |
| TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-α Production and Enhancing T Cell Activation A Psarras, A Antanaviciute, A Alase, I Carr, M Wittmann, P Emery, ... The Journal of Immunology 206 (4), 785-796, 2021 | 57 | 2021 |
| B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus YM El‐Sherbiny, MY Md Yusof, A Psarras, EMA Hensor, KZ Kabba, ... Arthritis & Rheumatology 72 (5), 769-779, 2020 | 23 | 2020 |
| Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus LM Carter, A Alase, Z Wigston, A Psarras, A Burska, E Sutton, MYM Yusof, ... Arthritis & Rheumatology 75 (5), 697-710, 2023 | 12 | 2023 |
| Systemic sclerosis and silicone breast implant: a case report and review of the literature A Psarras, I Gkougkourelas, K Tselios, A Sarantopoulos, P Boura Case Reports in Rheumatology 2014 (1), 809629, 2014 | 12 | 2014 |
| Type 1 interferons: a target for immune-mediated inflammatory diseases (IMIDs) A Mathian, R Felten, ME Alarcon-Riquelme, A Psarras, P Mertz, F Chasset, ... Joint Bone Spine 91 (2), 105627, 2024 | 10 | 2024 |
| A cellular overview of immunometabolism in systemic lupus erythematosus A Psarras, A Clarke Oxford Open Immunology 4 (1), iqad005, 2023 | 10 | 2023 |
| A9. 05 Distinct subsets of interferon-stimulated genes are associated with incomplete and established systemic lupus erythematosus A Psarras, MYM Yusof, YM El-Sherbiny, EM Hensor, M Wittmann, ... Annals of the rheumatic diseases 75, A72, 2016 | 6 | 2016 |
| Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope MY Md Yusof, EMD Smith, S Ainsworth, K Armon, MW Beresford, M Brown, ... Rheumatology advances in practice 7 (3), rkad093, 2023 | 5 | 2023 |
| Keratinocytes: From passive targets to active mediators of systemic autoimmunity A Psarras, EM Vital Science Translational Medicine 14 (642), eabo3961, 2022 | 4 | 2022 |
| Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus A Psarras, EM Vital The New England journal of medicine 387 (16), 1528-1529, 2022 | 3 | 2022 |
| A9. 06 Analysis of cell-specific interferon response in systemic lupus erythematosus using a novel flow cytometric assay YM El-Sherbiny, MYM Yusof, EM Hensor, A Psarras, A Mohamed, ... Annals of the Rheumatic Diseases 75, A72, 2016 | 3 | 2016 |
| 71 Prediction of response to rituximab in SLE using a validated two-score system for interferon status A Alase, Z Wigston, A Burska, E Hensor, A Psarras, MYM Yusof, ... Lupus Science & Medicine 6 (Suppl 1), 2019 | 2 | 2019 |
| Plasmacytoid dendritic cells are functionally exhausted while non-haematopoietic sources of type I interferon dominate human autoimmunity A Psarras, A Alase, A Antanaviciute, IM Carr, MY Md Yusof, M Wittmann, ... bioRxiv, 502047, 2018 | 2 | 2018 |
| AB0115 CD14+ myeloid cells express the PDC markers BDCA-2, BDCA-4, CD123 upon differentiation in both healthy individuals and SLE patients A Psarras, Z Wigston, E Vital Annals of the Rheumatic Diseases 82, 1236, 2023 | 1 | 2023 |
Vital EMUniversity of Leeds確認したメール アドレス: leeds.ac.uk
